SCHEMBL32678784

SCHEMBL32678784

OCCNc1ccncn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
HTT P42858 1/20 0.50
HRH4 Q9H3N8 2/20 0.46
MAP4K4 O95819 3/20 0.45
CLK4 Q9HAZ1 3/20 0.45
JAK2 O60674 2/20 0.45
ROCK2 O75116 2/20 0.45
CLK2 P49760 2/20 0.45
GSK3B P49841 2/20 0.45
DYRK1A Q13627 2/20 0.45
TYK2 P29597 2/20 0.45
RPS6KB1 P23443 1/20 0.45
ROCK1 Q13464 1/20 0.45
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22110996 1.00 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL32678778 1.00 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL32678782 1.00 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL30775333 0.89 NUDT1 (0.56) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL18906038 0.89 NUDT1 (0.56) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL235705 0.87 NUDT1 (0.50) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL210080 0.85 NUDT1 (0.49) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL30195099 0.80 SMN1; SMN2 (0.54) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL5554310 0.80 SMN1; SMN2 (0.54) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL18684036 0.80 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4CYP2D6CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026041663-A1 P2X7 RECEPTOR ANTAGONISTS BREYE THERAPEUTICS APS (DK) 2026-02-26 WO disclosed